{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:32:31Z","timestamp":1791210751882,"version":"4.1.0"},"reference-count":190,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.annfar.2010.03.012","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T01:20:50Z","timestamp":1274145650000},"page":"e121-e134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["H\u00e9mostase et pr\u00e9\u00e9clampsie"],"prefix":"10.1016","volume":"29","author":[{"given":"A.-S.","family":"Ducloy-Bouthors","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annfar.2010.03.012_bib1","series-title":"Manuel d\u2019h\u00e9mostase","first-page":"19","article-title":"Physiologie de l\u2019h\u00e9mostase primaire","author":"Levy-Toledano","year":"1995"},{"key":"10.1016\/j.annfar.2010.03.012_bib2","series-title":"Manuel d\u2019h\u00e9mostase","first-page":"37","article-title":"Physiologie de la coagulation plasmatique","author":"Guilin","year":"1995"},{"key":"10.1016\/j.annfar.2010.03.012_bib3","series-title":"Manuel d\u2019h\u00e9mostase","first-page":"57","article-title":"Physiologie de la fibrinolyse","author":"Alessi","year":"1995"},{"key":"10.1016\/j.annfar.2010.03.012_bib4","series-title":"Manuel d\u2019h\u00e9mostase","first-page":"75","article-title":"Endoth\u00e9lium et h\u00e9mostase","author":"George","year":"1995"},{"key":"10.1016\/j.annfar.2010.03.012_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.annfar.2010.03.012_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1521-6934(03)00019-1","article-title":"Haemostasis in normal and abnormal pregnancy","volume":"17","author":"O\u2019Riordan","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-38897","article-title":"Hemostasis during normal pregnancy and puerperium","volume":"29","author":"Hellgren","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0037-1614518","article-title":"APC resistance and other haemostatic variables during pregnancy and puerperium","volume":"81","author":"Kjellberg","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0412.2002.810304.x","article-title":"The levels of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy","volume":"81","author":"Hayashi","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.annfar.2010.03.012_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0301-2115(96)02550-X","article-title":"Fibronectin and antithrombin as markers of pre-eclampsia in pregnancy","volume":"70","author":"Paternoster","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.03.012_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-2115(97)02734-6","article-title":"Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis","volume":"73","author":"Cerneca","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.03.012_bib12","first-page":"315","article-title":"Haemocoagulative modifications correlated with pregnancy","volume":"58","author":"Borrelli","year":"2006","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1471-0528.1994.tb13147.x","article-title":"Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia","volume":"101","author":"Halligan","year":"1994","journal-title":"BrJ Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood.V69.2.460.460","article-title":"Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors","volume":"69","author":"Kruithof","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2010.03.012_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.thromres.2004.05.012","article-title":"Plasma levels of thrombin activatable fibrinolysis inhibitor in normal and preeclamptic pregnant women","volume":"114","author":"Alacacio\u011flu","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.annfar.2010.03.012_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: An excessive maternal inflammatory response to pregnancy","volume":"180","author":"Redman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.gyobfe.2003.12.015","article-title":"Avanc\u00e9es dans la physiopathologie de la pr\u00e9-\u00e9clampsie\u00a0: place de la r\u00e9ponse inflammatoire","volume":"32","author":"Bretelle","year":"2004","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.annfar.2010.03.012_bib18","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1053\/plac.2002.0930","article-title":"Pre-eclampsia, the placenta and the maternal systemic inflammatory response - A review","volume":"24S","author":"Redman","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.annfar.2010.03.012_bib19","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.placenta.2007.02.008","article-title":"Cell-derived microparticles and complement activation in preeclampsia versus normal pregnancy","volume":"28","author":"Biro","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.annfar.2010.03.012_bib20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1471-0528.1981.tb01764.x","article-title":"Thrombocytopenia and macrothrobocytosis in gestational hypertension","volume":"88","author":"Giles","year":"1981","journal-title":"BrJ Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000293106","article-title":"The relationship between clinical signs and hypercoagulable state in toxemia of pregnancy","volume":"31","author":"Terao","year":"1991","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.annfar.2010.03.012_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-2007-994949","article-title":"Coagulation\/fibrinolysis disorder in patients with severe preeclampsia","volume":"25","author":"Kobayashi","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0020-7292(99)00078-8","article-title":"Predictive markers of pre eclampsia in hypertensive disorders of pregnancy","volume":"66","author":"Paternoster","year":"1999","journal-title":"Intern J Gynecol Obstet"},{"key":"10.1016\/j.annfar.2010.03.012_bib24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0002-9378(92)91689-8","article-title":"Platelet activation and vascular damage in gestational hypertension","volume":"166","author":"Ballegeer","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib25","first-page":"719","article-title":"Hemostasis in hypertensive disorders of pregnancy","volume":"71","author":"Saleh","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0002-9378(91)90435-T","article-title":"High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone","volume":"165","author":"Taylor","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib27","first-page":"163","article-title":"Von Willebrand factor multimeric levels and patterns in patients with severe preeclampsia","volume":"75","author":"Thorp","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1471-0528.1993.tb15264.x","article-title":"Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia","volume":"100","author":"Cadroy","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1055\/s-0038-1646429","article-title":"Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension?","volume":"66","author":"Caron","year":"1991","journal-title":"Thrombosis and haemostasis"},{"key":"10.1016\/j.annfar.2010.03.012_bib30","first-page":"728","article-title":"Relation between umbilical prostacyclin production and blood flow in the fetus","volume":"323","author":"M\u00e4lik\u00e4","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2010.03.012_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1034\/j.1600-0412.1999.780304.x","article-title":"Hemostatic variables as independent predictors for fetal growth retardation","volume":"78","author":"Schjetlein","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.annfar.2010.03.012_bib32","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0002-9378(94)70064-8","article-title":"The role of nitric oxide in the pathogenesis of preeclampsia","volume":"171","author":"Seligman","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jri.2004.01.001","article-title":"The ratio of interleukin (IL)-18\u00a0to IL-12\u00a0secreted by peripheral blood mononuclear cells is increased in normal pregnant subjects and decreased in pre-eclamptic patients","volume":"61","author":"Sakai","year":"2004","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.annfar.2010.03.012_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejogrb.2004.12.009","article-title":"Association of fibrinogen and C-reactive protein with severity of preeclampsia","volume":"121","author":"Ust\u00fcn","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.03.012_bib35","first-page":"426","article-title":"Maternal serum IL-16\u00a0levels were elevated in women with preeclampsia","volume":"10","author":"Yuping","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib36","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1182\/blood.V88.12.4426.bloodjournal88124426","article-title":"High blood levels of macrophage colony-stimulating factor in preeclampsia","volume":"88","author":"Hayashi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2010.03.012_bib37","first-page":"251","article-title":"Blood macrophage colony-stimulating factor and thrombin-antithrombin III complex concentrations in pregnancy and preeclampsia","volume":"315","author":"Hayashi","year":"1998","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.annfar.2010.03.012_bib38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mob.2001.117311","article-title":"Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia","volume":"185","author":"Gervasi","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ajog.2006.06.083","article-title":"The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants","volume":"195","author":"Andrews","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jri.2007.04.003","article-title":"Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism inwomen with preeclampsia","volume":"77","author":"Stonek","year":"2008","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.annfar.2010.03.012_bib41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14767050701483298","article-title":"CXCL10\/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia?","volume":"20","author":"Gotsch","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.annfar.2010.03.012_bib42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF03016833","article-title":"Platelet count may predict abnormal bleeding time among pregnant women with hypertension and preeclampsia","volume":"48","author":"McDonagh","year":"2001","journal-title":"Can J Anesth"},{"key":"10.1016\/j.annfar.2010.03.012_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00000542-198908000-00003","article-title":"Correlation between bleeding times and platelet counts in women with preeclampsia undergoing caesarean section","volume":"71","author":"Ramanathan","year":"1989","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2010.03.012_bib44","first-page":"334","article-title":"A prospective study investigations the mechanism of thrombocytopenia in preeclampsia","volume":"70","author":"Burrows","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib45","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/bja\/87.6.890","article-title":"Platelet function during pregnancy: an evaluation using PFA-100\u00a0analyser","volume":"87","author":"Vincelot","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2010.03.012_bib46","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/0002-9378(90)90673-U","article-title":"The natural history of thrombocytopenia associated with preeclampsia","volume":"163","author":"Katz","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00000542-199902000-00009","article-title":"Assesment of changes in coagulation in parturients with preeclampsia using thromboelastography","volume":"90","author":"Sharma","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2010.03.012_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9378(13)70291-6","article-title":"Non invasive measurement of platelet kinetics in normal and hypertensive pregnancies","volume":"170","author":"Rinder","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0049-3848(79)90161-0","article-title":"Platelet life-span in normal pregnancy and preeclampsia as determined by a non-radioisotope technique","volume":"15","author":"Rakoczi","year":"1979","journal-title":"Thromb Res"},{"key":"10.1016\/j.annfar.2010.03.012_bib50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00003081-199235020-00015","article-title":"Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia","volume":"35","author":"Perry","year":"1992","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2141.1982.tb01941.x","article-title":"Haemostatic and rheological changes in normal pregnancy and preeclampsia","volume":"50","author":"Inglis","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annfar.2010.03.012_bib52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0002-9378(87)80357-5","article-title":"Abnormalities in platelet antiglobulin tets in preeclamptic mothers and their neonates","volume":"157","author":"Samuels","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0002-9378(97)70516-7","article-title":"Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules","volume":"176","author":"Konijnenberg","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.thromres.2005.01.009","article-title":"Platelet activation in pregnancy-induced hypertension","volume":"116","author":"Karalis","year":"2005","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.annfar.2010.03.012_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09537100400004355","article-title":"Leukocyte-platelet interaction in pregnancies complicated with preeclampsia","volume":"16","author":"Holthe","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.annfar.2010.03.012_bib56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1471-0528.1994.tb13111.x","article-title":"Platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation","volume":"101","author":"Norris","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib57","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJM199008163230702","article-title":"Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women","volume":"323","author":"Zemel","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.03.012_bib58","first-page":"107","article-title":"A platelet function defect in preeclampsia","volume":"65","author":"Kelton","year":"1985","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/bja\/77.2.157","article-title":"Thromboelastography changes in pre-eclampsia and eclampsia","volume":"77","author":"Orlikowski","year":"1996","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.annfar.2010.03.012_bib60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000298799","article-title":"Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers","volume":"24","author":"Kobayashi","year":"1987","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.annfar.2010.03.012_bib61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9378(89)90096-3","article-title":"Enhanced thrombin generation in normal and hypertensive pregnancy","volume":"160","author":"De Boer","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1471-0528.1990.tb02520.x","article-title":"Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery","volume":"97","author":"Reinthaller","year":"1990","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib63","first-page":"29","article-title":"Antiphospholipid antibodies and preeclampsia: a case-control study","volume":"97","author":"Dreyfus","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib64","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0002-9378(84)90634-3","article-title":"Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity","volume":"148","author":"Weenink","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib65","first-page":"301","article-title":"Antithrombin III activity in women with hypertension during pregnancy","volume":"65","author":"Weiner","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0049-3848(86)90085-X","article-title":"Heparin cofactor activity and antithrombin III antigen levels in preeclampsia","volume":"43","author":"Friedman","year":"1986","journal-title":"Thromb Res"},{"key":"10.1016\/j.annfar.2010.03.012_bib67","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000067878","article-title":"Activated protein C resistance in normal and pre-eclamptic pregnancies","volume":"54","author":"Paternoster","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.annfar.2010.03.012_bib68","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1067\/mob.2001.109397","article-title":"Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women","volume":"184","author":"Bombeli","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0020-7292(03)00193-0","article-title":"Thrombin\u2013antithrombin complex and a -plasmin inhibitor\u2013 2\u00a0plasmin complex levels after cesarean section in normal pregnancies and pre-eclampsia","volume":"82","author":"Hayashi","year":"2003","journal-title":"International J Gynecol Obstet"},{"key":"10.1016\/j.annfar.2010.03.012_bib70","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14767050802034859","article-title":"Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation","volume":"21","author":"Erez","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.annfar.2010.03.012_bib71","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2353\/ajpath.2007.060465","article-title":"Thrombin regulates soluble fms-like Tyrosine Kinase-1 (sFlt-1) expression in first trimester decidua","volume":"170","author":"Lockwood","year":"2007","journal-title":"Am J Path"},{"key":"10.1016\/j.annfar.2010.03.012_bib72","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood-2005-09-3755","article-title":"Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II","volume":"107","author":"Tusar","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2010.03.012_bib73","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajog.2006.09.008","article-title":"Thrombin regulates monocyte chemoattractant protein-1\u00a0expression in human first-trimester and term decidual cells","volume":"196","author":"Matta","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib74","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ajog.2003.09.050","article-title":"Thrombin and PAR1-activating peptide: Effects on human uterine contractility in vitro","volume":"190","author":"O'Sullivan","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib75","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/jmf.11.6.362.367","article-title":"Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia","volume":"11","author":"Chaiworapongsa","year":"2002","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.annfar.2010.03.012_bib76","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0037-1613231","article-title":"Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents","volume":"88","author":"VanWijk","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000010206","article-title":"Immunohistochemical study of annexin V expression in placentae of preeclampsia","volume":"49","author":"Shu","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.annfar.2010.03.012_bib78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0028-2243(84)90133-3","article-title":"Recent aspects of hemostasis, hematology and hemorheology in preeclampsia-eclampsia","volume":"17","author":"Graeff","year":"1984","journal-title":"Eur J Obstet Gynec Reprod Biol"},{"key":"10.1016\/j.annfar.2010.03.012_bib79","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0002-9378(97)70100-5","article-title":"The procoagulant activity of red blood cells from patients with severe preeclampsia","volume":"177","author":"Grisaru","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib80","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0002-9378(99)70222-X","article-title":"Effects of red cells on the coagulation of blood in normal and preeclamptic pregnancies","volume":"180","author":"Kaibara","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1471-0528.1982.tb04676.x","article-title":"Blood viscosity and haemostatic factors in late pregnancy, pre-eclampsia and fetal growth retardation","volume":"89","author":"Thorburn","year":"1982","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib82","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0002-9378(85)90071-7","article-title":"Erythrocyte morphology in women with severe preeclampsia and eclampsia. Preliminary observations with scanning electron microscopy","volume":"153","author":"Cunningham","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib83","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1471-0528.1999.tb08327.x","article-title":"Maternal peripheral blood leucocytes in normal and preeclamptic pregnancies","volume":"106","author":"Von Dadelszen","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib84","first-page":"425","article-title":"Thrombomodulin release from umbilical endothelial cells initiated by preeclampsia plasma-induced neutrophil activation","volume":"92","author":"Kobayashi","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib85","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1471-0528.1999.tb08330.x","article-title":"Tissue factor levels and high ratio fibrinopeptide A: D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia","volume":"106","author":"Bellart","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib86","first-page":"1041","article-title":"Pathologic Features of the Placenta in Women With Severe Pregnancy Complications and Thrombophilia","volume":"98","author":"Many","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib87","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1538-7836.2005.01564.x","article-title":"Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment","volume":"3","author":"Aharon","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib88","first-page":"44","article-title":"Genetic hypofibrinolysis in complicated pregnancies","volume":"97","author":"Glueck","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib89","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1538-7836.2004.00861.x","article-title":"Preeclampsia and its interaction with common variants in thrombophilia genes","volume":"2","author":"De Maat","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib90","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.thromres.2004.05.012","article-title":"Plasma levels of thrombin activatable fibrinolysis inhibitor in normal and preeclamptic pregnant women","volume":"114","author":"Alacacio\u011flu","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.annfar.2010.03.012_bib91","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0037-1613269","article-title":"Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and\/or intrauterine fetal growth retardation ?","volume":"88","author":"Antovic","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib92","first-page":"176","article-title":"Changes in the thrombophilic status in patients with pre-eclampsia","volume":"67","author":"Baptista-Gonzalez","year":"1999","journal-title":"Ginecol Obstet Mex"},{"key":"10.1016\/j.annfar.2010.03.012_bib93","first-page":"607","article-title":"Analyse critique des troubles de 1\u2019h\u00e9mostase au cours de l\u2019\u00e9clampsie","volume":"27","author":"Mjahed","year":"1998","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.annfar.2010.03.012_bib94","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1182\/blood.V63.3.525.525","article-title":"Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia\/eclampsia","volume":"63","author":"Borok","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2010.03.012_bib95","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2141.1988.tb04184.x","article-title":"Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II. Evaluation in a variety of clinical conditions","volume":"68","author":"Gaffney","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annfar.2010.03.012_bib96","first-page":"435","article-title":"Use of the Fibrin D-Dimer in screening for coagulation abnormalities in preeclampsia","volume":"73","author":"Trofatter","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib97","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0038-1648415","article-title":"The predictive value of the hemostasis parameters in the development of preeclampsia","volume":"67","author":"Ho","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib98","first-page":"77","article-title":"D-Dimer in different stages of pregnancy toxemia. A pilot study","volume":"66","author":"Verduzco Rodriguez","year":"1998","journal-title":"Gynecol Obstet Mex"},{"key":"10.1016\/j.annfar.2010.03.012_bib99","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000291899","article-title":"Fibrinolysis during normal pregnancy and severe preeclampsia: relationships between plasma levels of plasminogen activators and inhibitors","volume":"42","author":"Nakashima","year":"1996","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.annfar.2010.03.012_bib100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/00016349709024580","article-title":"Markers of intravascular coagulation and fibrinolysis in preeclampsia : association with intrauterine growth retardation","volume":"76","author":"Schjetlein","year":"1997","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.annfar.2010.03.012_bib101","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00041552-199407000-00010","volume":"3","author":"Sibai","year":"1994","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.annfar.2010.03.012_bib102","series-title":"Insuffisance r\u00e9nale aigu\u00eb en r\u00e9animation","article-title":"Insuffisance r\u00e9nale aigu\u00eb du post-partum","author":"Pourrat","year":"2003"},{"key":"10.1016\/j.annfar.2010.03.012_bib103","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.03.012_bib104","first-page":"1029","article-title":"Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome","volume":"88","author":"Lattuada","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.annfar.2010.03.012_bib105","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/j.1538-7836.2006.02205.x","article-title":"Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome","volume":"4","author":"Hulstein","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib106","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2003-08-2744","article-title":"Clinical management of thrombophilia-related placental vascular complications","volume":"103","author":"Brenner","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2010.03.012_bib107","series-title":"Manuel d\u2019h\u00e9mostase","first-page":"507","article-title":"Le syndrome des anticorps antiphospholipides","author":"De Moerloose","year":"1995"},{"key":"10.1016\/j.annfar.2010.03.012_bib108","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2010.03.012_bib109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM199901073400102","article-title":"Increased frequency of genetic thrombophilia in women with complications of pregnancy","volume":"340","author":"Kupferminc","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.03.012_bib110","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0002-9378(99)70608-3","article-title":"High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia","volume":"180","author":"Van Pampus","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib111","first-page":"A1681","article-title":"Incidence of metabolic and hemostatic variables in 72\u00a0women with pregnancy-induced hypertension","volume":"82","author":"Peltier","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib112","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9378(96)80022-6","article-title":"The factor V Leiden may predispose women to severe preeclampsia","volume":"175","author":"Dizon-Townson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib113","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0002-9378(98)70025-0","article-title":"Resistance to activated protein C and the Leiden mutation: High prevalence in patients with abruptio placentae","volume":"179","author":"Wiener-Megnani","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib114","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0002-9378(95)91324-6","article-title":"Underlying disorders associated with severe early-onset preeclampsia","volume":"173","author":"Dekker","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib115","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0049-3848(00)00312-1","article-title":"Incidence of the Factor V Leidenmutation, Coagulation Inhibitor Deficiency, and Elevated Antiphospholipid-antibodies in Patients with Preeclampsia or HELLP Syndrome","volume":"100","author":"Von Tempelhoff","year":"2000","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.annfar.2010.03.012_bib116","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1471-0528.1997.tb10970.x","article-title":"H yperhomocysteinaemia and protein S deficiency in complicated pregnancies","volume":"104","author":"De Vries","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib117","first-page":"457","article-title":"Activated Protein C resistance and factor V leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome","volume":"92","author":"Krauss","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1471-0528.1999.tb08243.x","article-title":"The placenta in maternal hyperhomocysteinaemia","volume":"106","author":"Khong","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib119","first-page":"277","article-title":"Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta","volume":"7","author":"Arias","year":"1998","journal-title":"J Matern Fetal Med"},{"key":"10.1016\/j.annfar.2010.03.012_bib120","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0002-9378(99)70335-2","article-title":"Preeclampsia and genetic risk factors for thrombosis: a case-control study","volume":"181","author":"De Groot","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib121","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajog.2008.09.023","article-title":"Inherited Thrombophilia and preeclampsia within a multicenter cohort: the montreal preeclampsia study","volume":"200","author":"Kahn","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib122","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bcmd.2006.07.005","article-title":"Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population","volume":"37","author":"Dalm\u00e1z","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.annfar.2010.03.012_bib123","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib124","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1538-7836.2005.01185.x","article-title":"Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33\u00a0women treated with a rigorous protocol","volume":"3","author":"Stone","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib125","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1046\/j.1538-7836.2003.00253.x","article-title":"Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome","volume":"1","author":"Pauzner","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib126","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0248-8663(02)00013-9","article-title":"Antiphospholipid antibodies in HELLP syndrome: clinical and biological study in 68\u00a0women","volume":"24","author":"Queyrel","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annfar.2010.03.012_bib127","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1182\/blood.V88.11.4173.bloodjournal88114173","article-title":"Mechanism and Effects of the Binding of Lupus Anticoagulant IgG and Prothrombin to Surface Phospholipid","volume":"88","author":"Mohan Rao","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2010.03.012_bib128","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood.V93.7.2149","article-title":"Antiprothrombin antibodies: Detection and clinical significance in the antiphospholipid syndrome","volume":"93","author":"Galli","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2010.03.012_bib129","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood.V92.5.1652","article-title":"Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: A \u201cLupus procoagulant\u201d phenomenon","volume":"92","author":"Jacob","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2010.03.012_bib130","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(05)60080-3","article-title":"Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death","volume":"352","author":"Chamley","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2010.03.012_bib131","first-page":"CD002859","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","volume":"18","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annfar.2010.03.012_bib132","first-page":"292","article-title":"How often does maternal preeclampsiaeclampsia incite thrombocytopenia in the fetus?","volume":"69","author":"Pritchard","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib133","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0049-3848(81)90179-1","article-title":"Plasma levels of selected haemostatic factors in newborn babies","volume":"23","author":"Cederholm-Williams","year":"1981","journal-title":"Thromb Res"},{"key":"10.1016\/j.annfar.2010.03.012_bib134","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.mbc.0000164425.67674.90","article-title":"The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns","volume":"16","author":"Zanardo","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.annfar.2010.03.012_bib135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/107602960501100415","article-title":"Coagulation and fibrinolysis in preeclampsia and neonates","volume":"11","author":"Tanjung","year":"2005","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib136","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1080\/00016340600697272","article-title":"Newborns of pre-eclamptic women: a biochemical difference present in utero","volume":"85","author":"Ophir","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.annfar.2010.03.012_bib137","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-3848(03)00067-7","article-title":"Overall haemostasis potential assays performed in thrombophilic plasma: the effect of preactivating protein C and antithrombin","volume":"108","author":"Andresen","year":"2003","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.annfar.2010.03.012_bib138","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00000542-200005000-00008","article-title":"Thromboelastography Past, Present, and Future","volume":"92","author":"Whitten","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annfar.2010.03.012_bib139","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with antiphospholipid antibodies","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.annfar.2010.03.012_bib140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0301-2115(98)00083-9","article-title":"Low -molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study","volume":"80","author":"Riyazi","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.03.012_bib141","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.annfar.2010.03.012_bib142","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","article-title":"Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia","volume":"1","author":"Carp","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib143","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1538-7836.2004.00784.x","article-title":"Does heparin therapy improve pregnancy outcome in patients with thrombophilias?","volume":"2","author":"Paidas","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib144","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1538-7836.2004.00821.x","article-title":"Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications","volume":"2","author":"Grandone","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib145","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1538-7836.2004.00833.x","article-title":"Antithrombotic prophylaxis in women with thrombophilia and pregnancy complications","volume":"2","author":"Conard","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib146","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/10641950600745517","article-title":"Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone","volume":"25","author":"Sergio","year":"2006","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.annfar.2010.03.012_bib147","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1538-7836.2004.00818.x","article-title":"Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications","volume":"2","author":"Brenner","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib148","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecularweight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2010.03.012_bib149","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1471-0528.1975.tb00711.x","article-title":"Failure of heparin therapy to affect the clinical course of severe preeclampsia","volume":"82","author":"Howie","year":"1975","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0038-1648403","article-title":"Absence of transplacental passage of fragmin (Kabi) in the second and third trimesters of pregnancy","volume":"67","author":"Forestier","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib151","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejogrb.2005.09.010","article-title":"Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111\u00a0consecutive pregnancies","volume":"127","author":"Deruelle","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.03.012_bib152","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624\u00a0pregnancies","volume":"108","author":"Leperc","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.annfar.2010.03.012_bib153","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJM199804093381501","article-title":"Reduction of plasma homocyst(e)ine levels with folic acid in patients with coronary heart disease","volume":"338","author":"Malinow","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.03.012_bib154","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9378(90)90835-U","article-title":"Plasma exchange for preeclampsia","volume":"162","author":"Martin","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib155","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0002-9378(95)91470-6","article-title":"Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome","volume":"172","author":"Martin","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib156","first-page":"451","article-title":"Plasmapheresis during pregnancy","volume":"76","author":"Watson","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib157","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.transci.2005.08.010","article-title":"Daily plasma-exchange for lifethreatening class I HELLP syndrome with prevalent pulmonary involvement","volume":"34","author":"Del Fante","year":"2006","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.annfar.2010.03.012_bib158","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.transci.2006.05.010","article-title":"Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia","volume":"35","author":"Wang","year":"2006","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.annfar.2010.03.012_bib159","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","article-title":"Maternal morbidity and mortality in 442\u00a0pregnancies with hemolysis, elevated liver enzymes and low platelets","volume":"169","author":"Sibai","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib160","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00005344-199605000-00013","article-title":"Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia","volume":"27","author":"Shinyama","year":"1996","journal-title":"J Cardiovascular Pharmacol"},{"key":"10.1016\/j.annfar.2010.03.012_bib161","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V93.1.157","article-title":"Antithrombin reduces ischemia\/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin","volume":"93","author":"Harada","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.annfar.2010.03.012_bib162","first-page":"10","article-title":"Coagulopathy in preeclampsia","volume":"13","author":"Terao","year":"2000","journal-title":"Biomedical Progress"},{"key":"10.1016\/j.annfar.2010.03.012_bib163","first-page":"25","article-title":"Pathological state of the coagulatory and fibrinolytic system in preeclampsia and the possibility of its treatment with AT III concentrate. Asia-Oceania","volume":"15","author":"Terao","year":"1989","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib164","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(00)00268-X","article-title":"Treatment with antithrombin III AT III concentrate in preeclampsia","volume":"71","author":"Paternoster","year":"2000","journal-title":"Intern J Gynecol Obstet"},{"key":"10.1016\/j.annfar.2010.03.012_bib165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1160\/TH03-06-0388","article-title":"Efficacy of AT in preeclampsia: a case-control prospective trial","volume":"91","author":"Paternoster","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib166","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(02)02925-4","article-title":"Anti-thrombin action of low-dose acetylsalicylic acid","volume":"460","author":"Di Micco","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.annfar.2010.03.012_bib167","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1055\/s-0037-1615902","article-title":"Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation","volume":"82","author":"Maruyama","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.03.012_bib168","series-title":"Manuel d\u2019h\u00e9mostase","first-page":"757","article-title":"Les antithrombotiques\u00a0: perspectives","author":"Eschwege","year":"1995"},{"key":"10.1016\/j.annfar.2010.03.012_bib169","doi-asserted-by":"crossref","first-page":"I19","DOI":"10.1515\/jpme.1996.24.2.119","article-title":"Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cells dysfunction in preeclampsia; therapeutic perspectives","volume":"24","author":"Dekker","year":"1996","journal-title":"J Perinat Med"},{"key":"10.1016\/j.annfar.2010.03.012_bib170","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2005.11.038","article-title":"Addition of platelet transfusions to corticosteroids does not increase the recovery of severe HELLP syndrome","volume":"128","author":"Vigil-De Gracia","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.03.012_bib171","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0002-9378(94)90054-X","article-title":"Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)","volume":"171","author":"Magann","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib172","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1067\/mob.2000.108869","article-title":"Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome","volume":"183","author":"O\u2019Brien","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib173","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1067\/S0002-9378(03)00763-4","article-title":"Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome","volume":"189","author":"Martin","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib174","doi-asserted-by":"crossref","unstructured":"Martin JN, MD, Rose CH, Briery CM. Understanding and managing HELLP syndrome: The integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006;195:914\u201334.","DOI":"10.1016\/j.ajog.2005.08.044"},{"key":"10.1016\/j.annfar.2010.03.012_bib175","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1067\/mob.2001.115051","article-title":"A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome","volume":"184","author":"Isler","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib176","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0002-9378(99)70552-1","article-title":"HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: The benefit of corticosteroids","volume":"181","author":"Tompkins","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib177","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0301-2115(99)00022-6","article-title":"Corticosteroid therapy for conservative management in marginally-viable pregnancy complicated by HELLP syndrome","volume":"85","author":"Dreyfus","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.03.012_bib178","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0049-3848(01)00234-1","article-title":"Time Course of Recovery and Complications of HELLP. Syndrome with Two Different Treatments: Heparin or Dexamethasone","volume":"102","author":"Mecacci","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.annfar.2010.03.012_bib179","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0020-7292(98)00036-8","article-title":"Effects of postpartum corticosteroids in patients with HELLP syndrome","volume":"61","author":"Yalcin","year":"1998","journal-title":"Intern J Gynecol Obstet"},{"key":"10.1016\/j.annfar.2010.03.012_bib180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0020-7292(02)00394-6","article-title":"Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndrome","volume":"80","author":"Isler","year":"2003","journal-title":"Intern J Gynecol Obstet"},{"key":"10.1016\/j.annfar.2010.03.012_bib181","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0020-7292(97)00214-2","article-title":"Dexamethasone in the post-partum treatment of HELLP syndrome","volume":"59","author":"Vigil-De Gracia","year":"1997","journal-title":"Intern J Gynecol Obstet"},{"key":"10.1016\/j.annfar.2010.03.012_bib182","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0301-2115(98)00108-0","article-title":"Is conservative treatment of HELLP syndrome safe?","volume":"80","author":"Tsatsaris","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.03.012_bib183","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.ajog.2005.07.037","article-title":"Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: A double-blind, placebo-controlled, randomized clinical trial","volume":"193","author":"Fonseca","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib184","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00003081-198528010-00003","article-title":"Abruptio placentae with coagulopathy: a rational basis for management","volume":"28","author":"Sher","year":"1985","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.03.012_bib185","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1399-6576.2007.01323.x","article-title":"An open non-randomized study of recombinant activated factor VII in major post-partum haemorrhage","volume":"51","author":"Ahonen","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.annfar.2010.03.012_bib186","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000298866","article-title":"Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics","volume":"23","author":"Maki","year":"1987","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.annfar.2010.03.012_bib187","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000244469","article-title":"Antithrombin-III substitution in preterm infants-effects on intracranial hemorrhage and coagulation parameters","volume":"72","author":"Bragenberg","year":"1997","journal-title":"Biol Neonate"},{"key":"10.1016\/j.annfar.2010.03.012_bib188","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(98)10265-9","article-title":"Thrombosis in pregnancy: maternal and fetal issues","volume":"353","author":"Greer","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2010.03.012_bib189","unstructured":"Pr\u00e9vention de la maladie thromboembolique veineuse p\u00e9riop\u00e9ratoire et obst\u00e9tricale. Recommandations pour la pratique clinique. SFAR 2005."},{"key":"10.1016\/j.annfar.2010.03.012_bib190","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ajog.2007.08.041","article-title":"Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium-a register-based case-control study","volume":"198","author":"Jacobsen","year":"2008","journal-title":"Am J Obstet Gynecol"}],"container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765810001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765810001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:13:03Z","timestamp":1760091183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0750765810001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":190,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0750765810001206"],"URL":"https:\/\/doi.org\/10.1016\/j.annfar.2010.03.012","relation":{},"ISSN":["0750-7658"],"issn-type":[{"value":"0750-7658","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H\u00e9mostase et pr\u00e9\u00e9clampsie","name":"articletitle","label":"Article Title"},{"value":"Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annfar.2010.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}